James Rolke - 29 Oct 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Executive Officer, Director
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke
Issuer symbol
REVB
Transactions as of
29 Oct 2025
Net transactions value
+$499,986
Form type
4
Filing time
31 Oct 2025, 12:58:15 UTC
Previous filing
13 Feb 2025
Next filing
12 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rolke James Chief Executive Officer, Director C/O REVELATION BIOSCIENCES, INC., 4660 LA JOLLA VILLAGE DR., SUITE 100, SAN DIEGO /s/ J.P. Galda, as attorney-in-fact for James Rolke 30 Oct 2025 0001693858

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $499,986 +390,614 +3888% $1.28 400,660 29 Oct 2025 Direct F1
holding REVB Common Stock 10,046 29 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the grant date.